ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone
At the time of diagnosis, 20% of patients with colorectal cancer present metastasis. Among individuals with primary lesions, 50% of them will develop distant tumours with time. Therefore, early diagnosis and prediction of aggressiveness is crucial for therapy design and disease prognosis. Tumoral ce...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-10-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.12367 |
| _version_ | 1818417933428195328 |
|---|---|
| author | Cristina Aguirre‐Portolés Jaime Feliu Guillermo Reglero Ana Ramírez de Molina |
| author_facet | Cristina Aguirre‐Portolés Jaime Feliu Guillermo Reglero Ana Ramírez de Molina |
| author_sort | Cristina Aguirre‐Portolés |
| collection | DOAJ |
| description | At the time of diagnosis, 20% of patients with colorectal cancer present metastasis. Among individuals with primary lesions, 50% of them will develop distant tumours with time. Therefore, early diagnosis and prediction of aggressiveness is crucial for therapy design and disease prognosis. Tumoral cells must undergo significant changes in energy metabolism to meet increased structural and energetic demands for cell proliferation, and metabolic alterations are considered to be a hallmark of cancer. Here, we present the ATP‐binding cassette transporter (ABCA1), a regulator of cholesterol transport, as a new marker for invasion and colorectal cancer survival. ABCA1 is significantly overexpressed in patients at advanced stages of colorectal cancer, and its overexpression confers proliferative advantages together with caveolin‐1 dependent‐increased migratory and invasive capacities. Thus, intracellular cholesterol imbalances mediated by ABCA1 overexpression may contribute to primary tumour growth and dissemination to distant locations. Furthermore, we demonstrate here that increased levels of apolipoprotein A1 (APOA1), a protein involved in cholesterol efflux and high‐density lipoprotein constitution, in the extracellular compartment modulates expression of ABCA1 by regulating COX‐2, and compensate for ABCA1‐dependent excessive export of cholesterol. APOA1 emerges as a new therapeutic option to inhibit the promotion of colorectal cancer to metastasis by modulating intracellular cholesterol metabolism. Furthermore, we propose apabetalone, an orally available small molecule that is currently being evaluated in clinical trials for the treatment of atherosclerosis, as a new putative therapeutic option to prevent colorectal cancer progression by increasing APOA1 expression and regulating reverse transport of cholesterol. |
| first_indexed | 2024-12-14T12:14:39Z |
| format | Article |
| id | doaj.art-556a4cd04382499f8d2f42cfec59e8e5 |
| institution | Directory Open Access Journal |
| issn | 1574-7891 1878-0261 |
| language | English |
| last_indexed | 2024-12-14T12:14:39Z |
| publishDate | 2018-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | Molecular Oncology |
| spelling | doaj.art-556a4cd04382499f8d2f42cfec59e8e52022-12-21T23:01:40ZengWileyMolecular Oncology1574-78911878-02612018-10-0112101735175210.1002/1878-0261.12367ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetaloneCristina Aguirre‐Portolés0Jaime Feliu1Guillermo Reglero2Ana Ramírez de Molina3Molecular Oncology IMDEA Food Institute CEI UAM + CSIC Madrid SpainMedical Oncology La Paz University Hospital (IdiPAZ) CIBERONC, cátedra UAM‐AMGEN Madrid SpainMolecular Oncology IMDEA Food Institute CEI UAM + CSIC Madrid SpainMolecular Oncology IMDEA Food Institute CEI UAM + CSIC Madrid SpainAt the time of diagnosis, 20% of patients with colorectal cancer present metastasis. Among individuals with primary lesions, 50% of them will develop distant tumours with time. Therefore, early diagnosis and prediction of aggressiveness is crucial for therapy design and disease prognosis. Tumoral cells must undergo significant changes in energy metabolism to meet increased structural and energetic demands for cell proliferation, and metabolic alterations are considered to be a hallmark of cancer. Here, we present the ATP‐binding cassette transporter (ABCA1), a regulator of cholesterol transport, as a new marker for invasion and colorectal cancer survival. ABCA1 is significantly overexpressed in patients at advanced stages of colorectal cancer, and its overexpression confers proliferative advantages together with caveolin‐1 dependent‐increased migratory and invasive capacities. Thus, intracellular cholesterol imbalances mediated by ABCA1 overexpression may contribute to primary tumour growth and dissemination to distant locations. Furthermore, we demonstrate here that increased levels of apolipoprotein A1 (APOA1), a protein involved in cholesterol efflux and high‐density lipoprotein constitution, in the extracellular compartment modulates expression of ABCA1 by regulating COX‐2, and compensate for ABCA1‐dependent excessive export of cholesterol. APOA1 emerges as a new therapeutic option to inhibit the promotion of colorectal cancer to metastasis by modulating intracellular cholesterol metabolism. Furthermore, we propose apabetalone, an orally available small molecule that is currently being evaluated in clinical trials for the treatment of atherosclerosis, as a new putative therapeutic option to prevent colorectal cancer progression by increasing APOA1 expression and regulating reverse transport of cholesterol.https://doi.org/10.1002/1878-0261.12367ATP‐binding cassette transporterapabetalonecolorectal cancer prognosisreverse cholesterol transport |
| spellingShingle | Cristina Aguirre‐Portolés Jaime Feliu Guillermo Reglero Ana Ramírez de Molina ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone Molecular Oncology ATP‐binding cassette transporter apabetalone colorectal cancer prognosis reverse cholesterol transport |
| title | ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone |
| title_full | ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone |
| title_fullStr | ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone |
| title_full_unstemmed | ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone |
| title_short | ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone |
| title_sort | abca1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin 1 dependent invasiveness and these effects can be ameliorated using the bet inhibitor apabetalone |
| topic | ATP‐binding cassette transporter apabetalone colorectal cancer prognosis reverse cholesterol transport |
| url | https://doi.org/10.1002/1878-0261.12367 |
| work_keys_str_mv | AT cristinaaguirreportoles abca1overexpressionworsenscolorectalcancerprognosisbyfacilitatingtumourgrowthandcaveolin1dependentinvasivenessandtheseeffectscanbeamelioratedusingthebetinhibitorapabetalone AT jaimefeliu abca1overexpressionworsenscolorectalcancerprognosisbyfacilitatingtumourgrowthandcaveolin1dependentinvasivenessandtheseeffectscanbeamelioratedusingthebetinhibitorapabetalone AT guillermoreglero abca1overexpressionworsenscolorectalcancerprognosisbyfacilitatingtumourgrowthandcaveolin1dependentinvasivenessandtheseeffectscanbeamelioratedusingthebetinhibitorapabetalone AT anaramirezdemolina abca1overexpressionworsenscolorectalcancerprognosisbyfacilitatingtumourgrowthandcaveolin1dependentinvasivenessandtheseeffectscanbeamelioratedusingthebetinhibitorapabetalone |